Mumps and immunoglobulin (issued October 2008)
Updated 7 November 2024
Applies to England
© Crown copyright 2024
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/immunoglobulin-when-to-use/mumps-and-immunoglobulin-issued-october-2008
Human Normal Immunoglobulins (HNIG) is not recommended for post-exposure protection since there is no evidence that it is effective. There is no mumps-specific immunoglobulin available. Measles, mumps and rubella (MMR) vaccine is not effective when given for post-exposure prophylaxis.